. 2017 Nov 20;35(1):78–88. doi: 10.1111/dme.13537

Table 1.

Candidate prognostic factors for healing of infected diabetic foot ulcer

Baseline clinical characteristics	Baseline microbiology^a
Age Ulcer type (ischaemic or neuro‐ischaemic / neuropathic) Wagner system ulcer grade PEDIS classification: perfusion (grade ≥2 indicates peripheral arterial disease), extent, depth, infection, sensation Ulcer anatomical site Incident or recurrent ulcer Diabetes duration (in years) HbA_1c level (collected as DCCT %) Insulin therapy (yes or no) Type of diabetes (1 or 2) Wound duration (in months) On antibiotic therapy^b (yes or no) Antimicrobial dressing on ulcer^b	Presence of any reported pathogens Identification of most prevalent pathogens: 1 →Obligate anaerobes 2 →Gram‐positive cocci 3 →Gram‐negative bacilli 4 →Enterobacteriaceae 5 →Gram‐positive bacilli 6 →Staphylococcus aureus (all types) 7 →Methicillin‐resistant S. aureus 8 →Streptococcus spp 9 →Enterococcus spp 10 →Coagulase‐negative staphylococci 11 →Corynebacterium spp 12 →Pseudomonas spp

Baseline clinical characteristics

Baseline microbiology^a

Age
Ulcer type (ischaemic or neuro‐ischaemic / neuropathic)
Wagner system ulcer grade
PEDIS classification: perfusion (grade ≥2 indicates peripheral arterial disease), extent, depth, infection, sensation
Ulcer anatomical site
Incident or recurrent ulcer
Diabetes duration (in years)
HbA_1c level (collected as DCCT %)
Insulin therapy (yes or no)
Type of diabetes (1 or 2)
Wound duration (in months)
On antibiotic therapy^b (yes or no)
Antimicrobial dressing on ulcer^b

Presence of any reported pathogens
Identification of most prevalent pathogens:
- 1
  →Obligate anaerobes
- 2
  →Gram‐positive cocci
- 3
  →Gram‐negative bacilli
- 4
  →Enterobacteriaceae
- 5
  →Gram‐positive bacilli
- 6
  →Staphylococcus aureus (all types)
- 7
  →Methicillin‐resistant S. aureus
- 8
  →Streptococcus spp
- 9
  →Enterococcus spp
- 10
  →Coagulase‐negative staphylococci
- 11
  →Corynebacterium spp
- 12
  →Pseudomonas spp

DCCT, Diabetes Control and Complications Trial.

As reported in either swab or tissue sample

This refers to participants who were reported as receiving antibiotic therapy, or having an antimicrobial dressing on their ulcer, at the time immediately prior to their baseline assessment and wound culture.